RAI Plus Immunotherapy for Recurrent/Metastatic Thyroid Cancers
Clinical trial NCT03215095 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03215095
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-10
- Primary completion
- 2023-02-06
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.